Thursday, March 17, 2022 2:17:00 PM
I see a stock in limbo awaiting Q1 movement towards a clinical trial. Any clinical trial! A clinical trial hasn't been started at Algernon going on 2 years now. All we do is fuckin wait around as the paint dries at Algernon's new HQ location.
I expect the offering will be around $4 per share if they can get it. The same playbook as XORTX.
I also expect the share price will experience what Moreau calls "A Softening" of the share price after the offering
Meaning, 1 $ share price is not out of the realm of possibility. I'm thinking we will see 2 $ again no matter what happens.
Thanks Shell.
Is there anybody else out there?
M$
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM